Skip to main content
. 2020 Jul 28;21:308. doi: 10.1186/s12882-020-01960-0

Fig. 1.

Fig. 1

In situ expression of IL-6, IL-1β, and IL-4 in glomerular and tubulointerstitial compartments in patients with diabetic nephropathy (DN) and control group. a IL-6 expression in control and DN groups. b IL-6 immunostaining in control and DN groups. c IL-1β expression in control and DN groups. d IL-1β immunostaining in control and DN groups. e IL-4 expression in control group and DN groups. f IL-4 immunostaining in control and DN groups. Results are expressed as median (min-max). Horizontal lines represent the medians, the bars represent the 25–75% percentiles and the vertical lines represent the percentiles 10–90%